News

Latest Posts

European Leaders Fear Trump-Putin Call Signals US Concessions to Russia

After speaking with Vladimir Putin, President Trump plans to negotiate an end to the war in Ukraine. European leaders worry that Trump's conciliatory stance towards Russia may give in to Putin's demands without offering anything in return and that any deal made without Europe's involvement will not be lasting.

NIH Funding Cuts: Concerns, Lawsuits, and Market Impacts

Federal health research funding faces uncertainty after Trump administration cuts, raising concerns about potential impacts on the drug research world and biomedical research.

CFPB Consumer Complaint Portal Remains Open Despite Agency Freeze

Despite CFPB work freeze, consumers can still submit complaints through the agency's online portal. The system allows Americans to send complaints about financial institutions directly to the CFPB's database, which are then routed to the responsible company. Despite the freeze, the portal remains operational and unaffected by the work stoppage.

Trump's Reciprocal Tariff Order Could Rock World Economy

President Donald Trump announces plans to sign an executive order increasing US tariffs to match rates charged by other countries.

Trump's NIH Funding Cuts Halted, But Research World Braces for Long-Term Impact

Funding cuts to the National Institutes of Health (NIH) raise concerns over potential impacts on drug research and biomedical innovation, with experts warning of mass layoffs, project cancellations, and less US dominance in science and medicine.

European Leaders Push Back Against Trump's Ukraine-Russia Call

President Trump's call with Putin on Ukraine has raised concerns among European leaders, who fear being sidelined and giving Putin key concessions without guarantees. Despite US assurances, allies emphasize the need for European involvement in negotiations and continued investment in defense. Financial markets react, with Russian stocks rising and defense shares falling on prospects of a breakthrough in the war.

NIH Cuts: Legal Challenges, Market Impacts, and Research Tremors

Trump administration cuts to NIH "indirect costs" funding cause concern in the drug research world, with potential trickle-down effects on mass layoffs, project cancellations, and reductions in biomedical research. The move, aimed at saving the government $4 billion, has sparked a lawsuit by 22 states and a temporary halt by a federal judge.

BOJ to Raise Rates Again in H2, Economists Forecast

Economists anticipate the Bank of Japan will raise short-term interest rates in the second half of 2023, aiming to maintain Japan's inflation target of 2%.

Feds Cut NIH Indirect Costs: Drug Industry Silent Despite Research Cuts

Federal health research funding may see cuts, causing concern among researchers and drug developers. A judge has halted the cuts for now, but the situation remains uncertain, leading to warnings of mass layoffs and reduced biomedical research. Investors are wary, and long-term impacts on the industry and research are a concern.

Musk Withdraws Bid for OpenAI Nonprofit Arm

Elon Musk may abandon his bid to purchase OpenAI's non-profit division if the board agrees to maintain the charity's purpose.